The role of STAT5 in the development, function, and transformation of B and T lymphocytes

Annals of the New York Academy of Sciences

Volumn 1217, Issue 1, 2011, Pages 18-31

  Heltemes Harris, Lynn M ^a   Willette, Mark J L ^a   Vang, Kieng B ^a   Farrar, Michael A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Leukemia; Lymphocyte development; Lymphoma; STAT5; Transformation

Indexed keywords

CYTOKINE; GROWTH HORMONE RECEPTOR; REPRESSOR PROTEIN; STAT5 PROTEIN;

ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL TRANSFORMATION; CONTROLLED STUDY; GENE REPRESSION; HUMAN; LEUKEMIA; LYMPHOMA; NONHUMAN; PROTEIN FUNCTION; PROTEIN STRUCTURE; T LYMPHOCYTE; TH2 CELL;

EID: 79251560010     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05907.x     Document Type: Article

References (95)

1. Schindler, C. & J.E. Darnell, Jr. 1995. Transcriptional responses to polypepetide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64: 621-651.
2. Schindler, C., X.Y. Fu, T. Improta, et al 1992. Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha. Proc. Natl. Acad. Sci. USA 89: 7836-7839.
3. Greenlund, A.C., M.A. Farrar, B.L. Viviano & R.D. Schreiber 1994. Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO J. 13: 1591-1600.
4. Ihle, J.N. 1995. Cytokine receptor signalling. Nature 377: 591-594.
5. Copeland, N.G., D.J. Gilbert, C. Schindler, et al 1995. Distribution of the mammalian Stat gene family in mouse chromosomes. Genomics. 29: 225-228.
6. Lin, J.X., J. Mietz, W.S. Modi, et al 1996. Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells. J. Biol. Chem. 271: 10738-10744.
7. Cui, Y., G. Riedlinger, K. Miyoshi, et al 2004. Inactivation of Stat5 in mouse mammary epithelieum during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol. Cell Biol. 24: 8037-8047.
8. Liu, X., G.W. Robinson, K.U. Wagner, et al 1997. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes. Dev. 11: 179-186.
9. Udy, G.B., R.P. Towers, R.G. Snell, et al 1997. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA 94: 7239-7244.
10. Yao, Z., Y. Cui, W.T. Watford, et al 2006. Stat5a/b are essential for normal lymphoid development and differentiation. Proc. Natl. Acad. Sci. USA 103: 1000-1005.
11. Ota, N., T.J. Brett, T.L. Murphy, et al 2004. N-domain-dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation. Nat. Immunol. 5: 208-215.
12. Darnell, J.E., Jr. 1997. STATs and gene regulation. Science 277: 1630-1635.
13. John, S., U. Vinkemeier, E. Soldaini, et al 1999. The significance of tetramerization in promoter recruitment by Stat5. Mol. Cell Biol. 19: 1910-1918.
14. Pfitzner, E., R. Jahne, M. Wissler, et al 1998. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response. Mol. Endocrinol. 12: 1582-1593.
15. Nakajima, H., P.K. Brindle, M. Handa & J.N. Ihle 2001. Functional interaction of STAT5 and nuclear receptor co-repressor SMRT: implications in negative regulation of STAT5-dependent transcription. Embo J. 20: 6836-6844.
16. Xu, M., L. Nie, S.H. Kim & X.H. Sun 2003. STAT5-induced Id-1 transcription involves recruitment of HDAC1 and deacetylation of C/EBPbeta. EMBO J. 22: 893-904.
17. Rascle, A., J.A. Johnston & B. Amati 2003. Deacetylase activity is required for recruitment of the basal transcription machinery and transactivation by STAT5. Mol. Cell Biol. 23: 4162-4173.
18. Rascle, A. & E. Lees 2003. Chromatin acetylation and remodeling at the Cis promoter during STAT5-induced transcription. Nucl. Acids Res. 31: 6882-6890.
19. Desimone, A.M. & J.D. Laney Corepressor-directed preacetylation of histone h3 in promoter chromatin primes rapid transcriptional switching of cell-type-specific genes in yeast. Mol. Cell Biol. 30: 3342-3356.
20. Burchill, M.A., J. Yang, K.B. Vang, et al 2008. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 28: 112-121.
21. Sebastian, C., M. Serra, A. Yeramian, et al 2008. Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells. J. Immunol. 180: 5898-5906.
22. Teglund, S., C. McKay, E. Schuetz, et al 1998. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93: 841-850.
23. Moriggl, R., D.J. Topham, S. Teglund, et al 1999. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10: 249-259.
24. Kang, J., B. DiBenedetto, K. Narayan, et al 2004. STAT5 is required for thymopoiesis in a development stage-specific manner. J. Immunol. 173: 2307-2314.
25. Peschon, J.J., P.J. Morrissey, K.I. Grabstein, et al 1994. Early lymphocyte expansion is severely impaired in interleukin-7 receptor deficient mice. J. Exp. Med. 180: 1955-1960.
26. Burchill, M.A., C.A. Goetz, M. Prlic, et al 2003. Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells. J. Immunol. 171: 5853-5864.
27. Goetz, C.A., I.R. Harmon, J.J. O'Neil, et al 2004. STAT5 activation underlies IL7 receptor-dependent B cell development. J. Immunol. 172: 4770-4778.
28. Hoelbl, A., B. Kovacic, M.A. Kerenyi, et al 2006. Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. Blood 107: 4898-4906.
29. Burchill, M.A., J. Yang, C. Vogtenhuber, et al 2007. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 178: 280-290.
30. Yao, Z., Y. Kanno, M. Kerenyi, et al 2007. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 109: 4368-4375.
31. Park, J.H., S. Adoro, P.J. Lucas, et al 2007. 'Coreceptor tuning': cytokine signals transcriptionally tailor CD8 coreceptor expression to the self-specificity of the TCR. Nat. Immunol. 8: 1049-1059.
32. Park, J.H., S. Adoro, T. Guinter, et al 2010. Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells. Nat. Immunol. 11: 257-264.
33. Zhu, J., J. Cote-Sierra, L. Guo & W.E. Paul 2003. Stat5 activation plays a critical role in Th2 differentiation. Immunity 19: 739-748.
34. Vogtenhuber, C., C. Bucher, S.L. Highfill, et al 2010. Constitutively active Stat5b in CD4+ T-cells inhibits graft-versus-host disease (GVHD) lethality associated with increased regulatory T-cell (Treg) potency and decreased T effector cell (Teff) responses. Blood 116: 466-474.
35. Laurence, A., C.M. Tato, T.S. Davidson, et al 2007. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26: 371-381.
36. Sadlack, B., H. Merz, H. Schorle, et al 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253-261.
37. Willerford, D.M., J. Chen, J.A. Ferry, et al 1995. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3: 521-530.
38. Suzuki, H., T.M. Kundig, C. Furlonger, et al 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268: 1472-1476.
39. Lenardo, M.J. 1991. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353: 858-861.
40. Malek, T.R., B.O. Porter, E.K. Codias, et al 2000. Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors. J. Immunol. 164: 2905-2914.
41. Fontenot, J.D., J.P. Rasmussen, M.A. Gavin & A.Y. Rudensky 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151.
42. D'Cruz, L.M. & L. Klein 2005. Development and function of agonist-induced CD25(+)Foxp3(+) regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 6: 1152-1159.
43. Soper, D.M., D.J. Kasprowicz & S.F. Ziegler 2007. IL-2Rbeta links IL-2R signaling with Foxp3 expression. Eur. J. Immunol. 37: 1817-1826.
44. Antov, A., L. Yang, M. Vig, et al 2003. Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and maintenance of self-tolerance. J. Immunol. 171: 3435-3441.
45. Snow, J.W., N. Abraham, M.C. Ma, et al 2003. Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice. J. Immunol. 171: 5042-5050.
46. Lio, C.W. & C.S. Hsieh 2008. A two-step process for thymic regulatory T cell development. Immunity 28: 100-111.
47. Vang, K.B., J. Yang, A.J. Pagan, et al 2010. Cutting edge: CD28 and c-Rel-dependent pathways initiate regulatory T cell development. J. Immunol. 184: 4074-4077.
48. Lio, C.W., L.F. Dodson, C.M. Deppong, et al 2010. CD28 facilitates the generation of Foxp3(-) cytokine responsive regulatory T cell precursors. J. Immunol. 184: 6007-6013.
49. Isomura, I., S. Palmer, R.J. Grumont, et al 2009. c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells. J. Exp. Med. 206: 3001-3014.
50. Vang, K.B., J. Yang, S.A. Mahmud, et al 2008. IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development. J. Immunol. 181: 3285-3290.
51. Lord, J.D., B.C. McIntosh, P.D. Greenberg & B.H. Nelson 2000. The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5. J. Immunol. 164: 2533-2541.
52. Kondo, M., K. Akashi, J. Domen, et al 1997. Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common gamma chain-deficient mice. Immunity 7: 155-162.
53. -/- mice. Cell 89: 1011-1020.
54. Maraskovsky, E., J.J. Peschon, H. McKenna, et al 1998. Overexpression of Bcl-2 does not rescue impaired B lymphopoiesis in IL- 7 receptor-deficient mice but can enhance survival of mature B cells. Int. Immunol. 10: 1367-1375.
55. Lin, H. & R. Grosschedl 1995. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376: 263-267.
56. Urbanek, P., Z.Q. Wang, I. Fetka, et al 1994. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79: 901-912.
57. Roessler, S., I. Gyory, S. Imhof, et al 2007. Distinct promoters mediate the regulation of Ebf1 gene expression by interleukin-7 and Pax5. Mol. Cell Biol. 27: 579-594.
58. Kikuchi, K., A.Y. Lai, C.L. Hsu & M. Kondo 2005. IL-7 receptor signaling is necessary for stage transition in adult B cell development through up-regulation of EBF. J. Exp. Med. 201: 1197-1203.
59. Hirokawa, S., H. Sato, I. Kato & A. Kudo 2003. EBF-regulating Pax5 transcription is enhanced by STAT5 in the early stage of B cells. Eur. J. Immunol. 33: 1824-1829.
60. Goetz, C.A., I.R. Harmon, J.J. O'Neil, et al 2005. Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment. J. Immunol. 174: 7753-7763.
61. Scheeren, F.A., M. Naspetti, S. Diehl, et al 2005. STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression. Nat. Immunol. 6: 303-313.
62. Decker, T., M. Pasca di Magliano, S. McManus, et al 2009. Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis. Immunity 30: 508-520.
63. Medina, K.L., J.M. Pongubala, K.L. Reddy, et al 2004. Assembling a gene regulatory network for specification of the B cell fate. Dev. Cell 7: 607-617.
64. Chowdhury, D. & R. Sen 2001. Stepwise activation of the immunoglobulin mu heavy chain gene locus. EMBO J. 20: 6394-6403.
65. Johnson, K., C. Angelin-Duclos, S. Park & K.L. Calame 2003. Changes in histone acetylation are associated with differences in accessibility of V(H) gene segments to V-DJ recombination during B-cell ontogeny and development. Mol. Cell Biol. 23: 2438-2450.
66. Hewitt, S.L., B. Yin, Y. Ji, et al 2009. RAG-1 and ATM coordinate monoallelic recombination and nuclear positioning of immunoglobulin loci. Nat. Immunol. 10: 655-664.
67. Corcoran, A.E., A. Riddell, D. Krooshoop & A.R. Venkitaraman 1998. Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature 391: 904-907.
68. Bertolino, E., K. Reddy, K.L. Medina, et al 2005. Regulation of interleukin 7-dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5. Nat. Immunol. 6: 836-843.
69. Xu, C.R., L. Schaffer, S.R. Head & A.J. Feeney 2008. Reciprocal patterns of methylation of H3K36 and H3K27 on proximal vs. distal IgVH genes are modulated by IL-7 and Pax5. Proc. Natl. Acad. Sci. USA 105: 8685-8690.
70. Malin, S., S. McManus, C. Cobaleda, et al 2010. Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development. Nat. Immunol. 11: 171-179.
71. Zheng, Y., S. Josefowicz, A. Chaudhry, et al 2010. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463: 808-812.
72. Johnson, K., T. Hashimshony, C.M. Sawai, et al 2008. Regulation of immunoglobulin light-chain recombination by the transcription factor IRF-4 and the attenuation of interleukin-7 signaling. Immunity 28: 335-345.
73. Malin, S., S. McManus & M. Busslinger STAT5 in B cell development and leukemia. Curr. Opin. Immunol. 22: 168-176.
74. Pui, C.H., L.L. Robison & A.T. Look 2008. Acute lymphoblastic leukaemia. Lancet 371: 1030-1043.
75. Chai, S.K., G.L. Nichols & P. Rothman 1997. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients. J. Immunol. 159: 4720-4728.
76. Yoda, A., Y. Yoda, S. Chiaretti, et al 2010. Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA 107: 252-257.
77. Sillaber, C., F. Gesbert, D.A. Frank, et al 2000. STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells. Blood 95: 2118-2125.
78. Buettner, R., L.B. Mora & R. Jove 2002. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin. Cancer Res. 8: 945-954.
79. Schwaller, J., E. Parganas, D. Wang, et al 2000. Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. Mol. Cell 6: 693-704.
80. Weber-Nordt, R.M., C. Egen, J. Wehinger, et al 1996. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 88: 809-816.
81. Gouilleux-Gruart, V., F. Debierre-Grockiego, F. Gouilleux, et al 1997. Activated Stat related transcription factors in acute leukemia. Leuk Lymphoma 28: 83-88.
82. Nakayama, J., M. Yamamoto, K. Hayashi, et al 2009. BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3. Blood 113: 1483-1492.
83. Joliot, V., F. Cormier, H. Medyouf, et al 2006. Constitutive STAT5 activation specifically cooperates with the loss of p53 function in B-cell lymphomagenesis. Oncogene 25: 4573-4584.
84. Mullighan, C.G., J. Zhang, R.C. Harvey, et al 2009. JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA 106: 9414-9418.
85. Bercovich, D., I. Ganmore, L.M. Scott, et al 2008. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome. Lancet 372: 1484-1492.
86. Kearney, L., D. Gonzalez De Castro, J. Yeung, et al 2009. Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia. Blood 113: 646-648.
87. Samoszuk, M. & L. Nansen 1990. Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 75: 13-16.
88. Kapp, U., W.C. Yeh, B. Patterson, et al 1999. Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J. Exp. Med. 189: 1939-1946.
89. Foss, H.D., M. Hummel, S. Gottstein, et al 1995. Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease. Am. J. Pathol. 146: 33-39.
90. Merz, H., F.A. Houssiau, K. Orscheschek, et al 1991. Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood 78: 1311-1317.
91. Nielsen, M., K. Kaltoft, M. Nordahl, et al 1997. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proc. Natl. Acad. Sci. USA 94: 6764-6769.
92. Zhang, Q., I. Nowak, E.C. Vonderheid, et al 1996. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc. Natl. Acad. Sci. USA 93: 9148-9153.
93. Chen, H., J.M. Lee, Y. Zong, et al 2001. Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors. J. Virol. 75: 2929-2937.
94. Hinz, M., P. Lemke, I. Anagnostopoulos, et al 2002. Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J. Exp. Med. 196: 605-617.
95. Scheeren, F.A., S.A. Diehl, L.A. Smit, et al 2008. IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis. Blood 111: 4706-4715.